Investment ThemesDetailed Quotes
Gene Editing
Watchlist
Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
- 1389.913
- +11.267+0.82%
Close Nov 22 16:00 ET
1396.912High1378.189Low
1393.782Open1378.646Pre Close30.34MVolume9Rise69.78P/E (Static)1.09BTurnover--Flatline2.11%Turnover Ratio166.88BMarket Cap1Fall164.69BFloat Cap
Constituent Stocks: 10Top Rising: BLUE+17.85%
📊⚡️📊
📊⚡️📊
Benzinga· 3 mins ago
Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain
Sangamo plans to initiate enrollment of patients in thePhase 1/2 study for ST-503 in mid-2025
Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for i...
At 4:02 p.m. ET, the three indices closed lower. The $Dow Jones Industrial Average (.DJI.US)$ was off 0.70%, losing 300 points. The $S&P 500 Index (.SPX.US)$ was down 1.32% and the $Nasdaq Composite Index (.IXIC.US)$ was off 2.24%.
MACRO
In macro, core retail sales grew by 0.1% month over month, lower than estimated. ...
No comment yet